Scleral Fixation Of The Light Adjustable Lens To Treat Aphakia In The Absence Of Capsular Support
Published 2024 - 42nd Congress of the ESCRS
Reference: PP25.04 | Type: Free paper | DOI: 10.82333/47v1-ak81
Authors: Julie Schallhorn* 1 , Jay Stewart 1
1Ophthalmology,University of California San Francisco,San Francisco,United States
Purpose
To describe the technique and outcomes of intrascleral haptic fixation of the Light Adjustable Lens to treat aphakia in the absence of capsular support.
Setting
University clinic of the University of California, San Francisco
Methods
This is a retrospective case series of all patients undergoing placement of a scleral-fixated light adjustable lens (LAL, Rx Sight, Aliso Viejo, CA, USA) from 10/2022 to 2/2023.
Results
A total of 5 patients (9 eyes) underwent scleral fixation using a modified 27g trochar technique. Cataract removal was performed in 2 patients (4 eyes) with severe lens subluxation due to Marfan's syndrome. 5 eyes (4 patients) had removal of a dislocated IOL performed at time of LAL placement. All patients received pars plana vitrectomy. Patients underwent lens adjustment starting at postoperative week 6 with a A median of 2 adjustments. All eyes were +0.5D of the intended target at 1 month after lock in. Intraoperative complications included breakage of the haptic occuring at time of primarly implantation in 2 eyes requiring IOL exchange during the same surgery. There were no postoperative complications related to the lens.
Conclusions
Scleral fixation of the LAL offers potential refractive benefits over conventional IOLs. Further study is required to assess long-term stability.